(Q46104210)

English

Treatment of severe hypercalcaemia with mithramycin and aminohydroxypropylidene bisphosphonate

scientific article published in July 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

Treatment of severe hypercalcaemia with mithramycin and aminohydroxypropylidene bisphosphonate (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

author name string

S H Ralston

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

S J Gallacher

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

F J Dryburgh

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

R A Cowan

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

I T Boyle

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

language of work or name

0 references

publication date

1 July 1988

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

8605

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

277

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992563-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992563-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of single and multiple intravenous infusions of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD) in the treatment of hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992563-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between serum and urinary calcium with particular reference to parathyroid activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992563-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(88)92563-9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2899259

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46104210&oldid=2092551311"